1-13 of 13
Einar Haukås
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Selinexor with Alternating Bortezomib or Lenalidomide Plus Dexamethasone in Transplant Ineligible Newly Diagnosed Multiple Myeloma Patients (SABLe), Nordic Myeloma Study Group 29/21

Ida Bruun Bruun Kristensen, Hanne Marie Norseth, Diana Loigom, Henrik Gregersen, Einar Haukås, Tobias S. S. Slørdahl, Robert Schou Pedersen, Damian L. Szatkowski, Fredrik Schjesvold, Thomas Lund
Journal: Blood
Blood (2024) 144 (Supplement 1): 1988.
https://doi.org/10.1182/blood-2024-194840
Published: 2024
Journal Articles

A Phase II Study Measuring MRD Negativity after Bispecific T-Cell Redirectors Talquetamab and Teclistamab Consolidation Used in Sequence As Part of First Line Treatment in Transplant Eligible Multiple Myeloma Patients (TALTEC), Nordic Myeloma Study Group

Diana Loigom, Tobias S. S. Slørdahl, Anna Lysén, Agoston Gyula Szabo, Tine Rosenberg, Lene Kongsgaard Nielsen, Jakub Krejcik, Anne Marit Sponaas, Kristine Misund, Nicolai Jacob Wewer Albrechtsen, Jakob Nordberg Nørgaard, Thomas Lund, Sarah Leeth Hansen Farmer, Einar Haukås, Kari Lenita Falck Moore, Tatjana Tratš, Claire Albrecht, Diptendu Santra, Pavel Smirnov, Margaret Doyle, Kathleen S Gray, Fredrik Schjesvold
Journal: Blood
Blood (2024) 144 (Supplement 1): 7016.
https://doi.org/10.1182/blood-2024-203364
Published: 2024
Journal Articles

Replacing Steroids in Transplant-Ineligible Multiple Myeloma: The Phase 2 Isatuximab-Bortezomib-Lenalidomide-Dexamethasone Rest Study

Frida Bugge Bugge Askeland, Einar Haukås, Tobias S. S. Slørdahl, Anja Klostergaard, Tatjana Alexandersen, Anna Lysén, Pegah Abdollahi, Emil Hermansen, Fredrik Schjesvold
Journal: Blood
Blood (2024) 144 (Supplement 1): 4730.
https://doi.org/10.1182/blood-2024-193864
Published: 2024
Journal Articles

Replacing Steroids in Transplant-Ineligible Multiple Myeloma: The Phase 2 Isatuximab-Bortezomib-Lenalidomide-Dexamethasone Rest Study

Frida Bugge Askeland, Einar Haukås, Tobias S. Slørdahl, Anja Klostergaard, Tatjana Alexandersen, Diana Schjøll, Anna Lysen, Emil Hermansen, Fredrik Schjesvold
Journal: Blood
Blood (2023) 142 (Supplement 1): 3381.
https://doi.org/10.1182/blood-2023-173126
Published: 2023
Journal Articles

Will Survival Improve By Treating Multiple Myeloma Patients at MRD Relapse? the Remnant Study

Frida Bugge Askeland, Anne-Marie Rasmussen, Anna Lysen, Einar Haukås, Anette Løken Eilertsen, Magnus Moksnes, Galina Tsykunova, Anders Vik, Birgitte Dahl Eiken, Vidar Stavseth, Jürgen Rolke, Eivind Ottersen Samstad, Valdas Peceliunas, Randi Fykse Hallstensen, Ariane Aasbø Hansen, Anita Smith Nilsen, Tobias S. Slørdahl, Fredrik Schjesvold
Journal: Blood
Blood (2023) 142 (Supplement 1): 4755.
https://doi.org/10.1182/blood-2023-189022
Published: 2023
Journal Articles

Replacing Steroids in Transplant-Ineligible Multiple Myeloma: The Phase 2 Isatuximab-Bortezomib-Lenalidomide-Dexamethasone Rest Study

Frida Bugge Bugge Askeland, Einar Haukås, Tobias S. Slørdahl, Diana Schjøll, Anna Lysén, Emil Hermansen, Fredrik Schjesvold
Journal: Blood
Blood (2022) 140 (Supplement 1): 12623–12625.
https://doi.org/10.1182/blood-2022-156625
Published: 2022
Journal Articles

Cold agglutinin disease revisited: a multinational, observational study of 232 patients

Sigbjørn Berentsen, Wilma Barcellini, Shirley D’Sa, Ulla Randen, Tor Henrik Anderson Tvedt, Bruno Fattizzo, Einar Haukås, Megan Kell, Robert Brudevold, Anders E. A. Dahm, Jakob Dalgaard, Hege Frøen, Randi Fykse Hallstensen, Pernille H. Jæger, Henrik Hjorth-Hansen, Agnieszka Małecka, Markku Oksman, Jürgen Rolke, Mallika Sekhar, Jon Hjalmar Sørbø, Eirik Tjønnfjord, Galina Tsykunova, Geir E. Tjønnfjord
Journal: Blood
Blood (2020) 136 (4): 480–488.
https://doi.org/10.1182/blood.2020005674
Published: 2020
Includes: Supplemental data
Journal Articles

Ixazomib-Thalidomide-Low Dose Dexamethasone (ITd) Induction Followed By Maintenance Therapy with Ixazomib or Placebo in Newly Diagnosed Multiple Myeloma Patients Not Eligible for Autologous Stem Cell Transplantation; Results from the Randomized Phase II HOVON-126/Nmsg 21#13 Trial

Sonja Zweegman, MDPhD, Fredrik H. Schjesvold, MDPhD, Bronno van der Holt, PhD, Mark-David Levin, MDPhD, Claudia A.M. Stege, MD, Anders Waage, MD PhD, Maria B.L. Leijs, MD, Saskia K. Klein, MDPhD, Damian L. Szatkowski, MDPhDMSc, Per Axelsson, MD, Trung Hieu Do, MD, Dorota Knut-Bojanovska, Ellen van der Spek, MDPhD, Asta Svirskaite, Pino Poddighe, MDPhD, Marian Stevens-Kroef, MD, Markus Hansson, MD PhD, Niels WCJ van de Donk, MD PhD, Einar Haukas, MD, Pieter Sonneveld, MDPhD, Niels Abildgaard, MDPhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 800.
https://doi.org/10.1182/blood-2018-99-111650
Published: 2018
Journal Articles

Bendamustine plus rituximab for chronic cold agglutinin disease: results of a Nordic prospective multicenter trial

Clinical Trials & Observations
Sigbjørn Berentsen, Ulla Randen, Markku Oksman, Henrik Birgens, Tor Henrik Anderson Tvedt, Jakob Dalgaard, Eivind Galteland, Einar Haukås, Robert Brudevold, Jon Hjalmar Sørbø, Inger Anne Næss, Agnieszka Malecka, Geir E. Tjønnfjord
Journal: Blood
Blood (2017) 130 (4): 537–541.
https://doi.org/10.1182/blood-2017-04-778175
Published: 2017
Journal Articles

Melphalan, prednisone, and lenalidomide versus melphalan, prednisone, and thalidomide in untreated multiple myeloma

Clinical Trials & Observations
Sonja Zweegman, Bronno van der Holt, Ulf-Henrik Mellqvist, Morten Salomo, Gerard M. J. Bos, Mark-David Levin, Heleen Visser-Wisselaar, Markus Hansson, Annette W. G. van der Velden, Wendy Deenik, Astrid Gruber, Juleon L. L. M. Coenen, Torben Plesner, Saskia K. Klein, Bea C. Tanis, Damian L. Szatkowski, Rolf E. Brouwer, Matthijs Westerman, M. (Rineke) B. L. Leys, Harm A. M. Sinnige, Einar Haukås, Klaas G. van der Hem, Marc F. Durian, E. (Vera) J. M. Mattijssen, Niels W. C. J. van de Donk, Marian J. P. L. Stevens-Kroef, Pieter Sonneveld, Anders Waage
Journal: Blood
Blood (2016) 127 (9): 1109–1116.
https://doi.org/10.1182/blood-2015-11-679415
Published: 2016
Includes: Supplemental data
Journal Articles

Randomized Phase III Trial in Non-Transplant Eligible Patients with Newly Diagnosed Symptomatic Multiple Myeloma Comparing Melphalan-Prednisone-Thalidomide Followed By Thalidomide Maintenance (MPT-T) Versus Melphalan-Prednisone-Lenalidomide Followed By Maintenance with Lenalidomide (MPR-R); A Joint Study of the Dutch-Belgian Cooperative Trial Group for Hematology Oncology (HOVON) and the Nordic Myeloma Study Group (NMSG)

Sonja Zweegman, MDPhD, Bronno van der Holt, PhD, Ulf-Henrik Mellqvist, MDPhD, Morten Salomo, MD, Gerard M.J. Bos, MDPhD, Mark-David Levin, MDPhD, Heleen A Visser-Wisselaar, PhD, Markus Hansson, MD PhD, Annette WG van der Velden, MD, Wendy Deenik, MDPhD, Astrid Gruber, MDPhD, Juleon LLM Coenen, MD, Torben Plesner, MD, Saskia K Klein, MDPhD, Bea Tanis, MDPhD, Damian L Szatkowski, MDPhDMSc, Rolf Brouwer, MDPhD, Matthijs Westerman, MD, M (Rineke) BL Leys, MDPhD, Niels W.C.J. van de Donk, MDPhD, Einar Haukås, MD, Klaas van der Hem, MD PhD, MF Durian, MD, E (Vera) JM Mattijssen, MDPhD, Harm AM Sinnige, MDPhD, Marian JPL Stevens-Kroef, PhD, Pieter Sonneveld, MDPhD, Anders Waage, MD PhD
Journal: Blood
Blood (2014) 124 (21): 179.
https://doi.org/10.1182/blood.V124.21.179.179
Published: 2014
Journal Articles

Bortezomib consolidation after autologous stem cell transplantation in multiple myeloma: a Nordic Myeloma Study Group randomized phase 3 trial

Clinical Trials & Observations
Ulf-Henrik Mellqvist, Peter Gimsing, Oyvind Hjertner, Stig Lenhoff, Edward Laane, Kari Remes, Hlif Steingrimsdottir, Niels Abildgaard, Lucia Ahlberg, Cecilie Blimark, Inger Marie Dahl, Karin Forsberg, Tobias Gedde-Dahl, Henrik Gregersen, Astrid Gruber, Nina Guldbrandsen, Einar Haukås, Kristina Carlson, Ann Kristin Kvam, Hareth Nahi, Roald Lindås, Niels Frost Andersen, Ingemar Turesson, Anders Waage, Jan Westin
Journal: Blood
Blood (2013) 121 (23): 4647–4654.
https://doi.org/10.1182/blood-2012-11-464503
Published: 2013
Journal Articles

Melphalan and prednisone plus thalidomide or placebo in elderly patients with multiple myeloma

Clinical Trials & Observations
Anders Waage, Peter Gimsing, Peter Fayers, Niels Abildgaard, Lucia Ahlberg, Bo Björkstrand, Kristina Carlson, Inger Marie Dahl, Karin Forsberg, Nina Gulbrandsen, Einar Haukås, Øyvind Hjertner, Martin Hjorth, Torbjörn Karlsson, Lene Meldgaard Knudsen, Johan Lanng Nielsen, Olle Linder, Ulf-Henrik Mellqvist, Ingerid Nesthus, Jürgen Rolke, Maria Strandberg, Jon Hjalmar Sørbø, Finn Wisløff, Gunnar Juliusson, Ingemar Turesson, for the Nordic Myeloma Study Group
Journal: Blood
Blood (2010) 116 (9): 1405–1412.
https://doi.org/10.1182/blood-2009-08-237974
Published: 2010